CSI Market
Sign In | Register

Tarsus Pharmaceuticals Inc (TARS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TARS Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Tarsus Pharmaceuticals Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TARS/balance-sheets
https://api.csimarket.com/api/v1/companies/TARS/fundamentals
https://api.csimarket.com/api/v1/companies/TARS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent136.53
Restricted Cash0.00
Marketable Securities, Current SH173.08
Cash & Short-term Investments309.00
Accounts receivable100.44
Other Receivables, Net, Current1.67
Inventories5.16
Other Current Assets0.00
Prepaid Expense, Current AS28.54
Total Current Assets445.42
Equipment/Property/Plant Net23.45
Intangible Assets16.65
Long-term investments6.68
Deferred, Prepaid and Other Assets, Noncurrent1.46
Other Assets, Noncurrent11.85
Restricted Cash Current-
Cash And Cash Equivalents Fair Value Disclosure102.19
Operating Lease Right Of Use Asset9.99
Total Assets505.50
Liabilities
Accounts Payable, Current AC34.69
Employee-related Liabilities, Current AC34.34
Other Liabilities, Current152.42
Taxes Payable5.67
Total Current Liabilities227.11
Long-term debt72.94
Total Long-term Debt72.94
Other liabilities, Noncurrent101.42
Total Liabilities401.47
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,225.42
Retained Earnings / Accumulated Deficit-1,120.48
Accumulated Other Comprehensive Income-0.91
Other Equity-0.91
Common Stockholder's Equity104.03
Total Stockholder's Equity104.03
Liabilities & Stockholder's Equity505.50
4 historic quarters locked

Sign in to unlock the full Tarsus Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Tarsus Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001819790-26-000076

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI